Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:



Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue
Vol 17
No 1
Jan/Feb 2026
Two Heads Are Better Than One Second Opinions and Collaborations in Oncology
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
January 14, 2026
The Use of Remote Monitoring in Care Management for Bone Marrow Transplant Patients
Susan L. Moore, PhD, MSPH, Karen Eleanor Rawlinson, Sarah R. Montoya, Et al.
January 14, 2026
Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer An Integrative Review
Jill Pontinen, PA-C, MPAS, Emily Lemke, DNP, AGPCNP-BC, AOCNP
January 14, 2026